Häuser, Winfried
Ablin, Jacob
Fitzcharles, Mary-Ann
Littlejohn, Geoffrey
Luciano, Juan V.
Usui, Chie
Walitt, Brian
Article History
First Online: 13 August 2015
Competing interests
: B.W., J.V.L. and C.U. declare no competing interests. J.A. has received research funding and participated in educational activity sponsored by Pfizer. M.-A.F. has received consulting fees, speaking fees and/or honoraria from BioVale, Janssen, Eli Lilly, Pfizer, Purdue and Valeant. W.H. received one consulting fee from Daiichi Sankyo and honoraria for educational lectures by Abbott, MSD, Sharp & Dohme and Pfizer. G.L. has been involved in clinical trials for Pfizer and Eli Lilly at Monash Health and received consulting and/or speaking fees from Pfizer, Eli Lilly, Mundipharma, Grünenthal, bioCSL and Pierre Fabre Medicament Australia.